NCT00507052

Brief Summary

In our opinion, it is worth to check an ability of antioxidant therapy to produce a favorable effect on Residual Renal Function. The aim of our study is to investigate the effect of N-acetylsysteine on RRF in prevalent HD patients.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 24, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 25, 2007

Completed
Last Updated

July 25, 2007

Status Verified

July 1, 2007

First QC Date

July 24, 2007

Last Update Submit

July 24, 2007

Conditions

HemodialysisRenal Failure

Keywords

HemodialysisResidual Renal Function

Interventions

N-acetylcysteineDRUG

Eligibility Criteria

Age20 Years - 90 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with ESRD, treated with chronic hemodialysis

You may not qualify if:

  • Patients will be excluded from the study if they are:
  • Patients with acute renal failure
  • Currently treated with antioxidants ( NAC, vitamin E ets.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assaf Harofeh

Ẕerifin, 70300, Israel

Location

MeSH Terms

Conditions

Renal Insufficiency

Interventions

Acetylcysteine

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

CysteineAmino Acids, SulfurSulfur CompoundsOrganic ChemicalsAmino AcidsAmino Acids, Peptides, and Proteins

Study Officials

  • Leonid S Feldman, MD

    Assaf Harofeh MC

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Leonid S Feldman, MD

CONTACT

+972-8-9779383leonidf@asaf.health.gov.il

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

July 24, 2007

First Posted

July 25, 2007

Last Updated

July 25, 2007

Record last verified: 2007-07

Locations

IL(1)